Intelivation Technologies receives FDA approval for Advantage-C PEEK cervical interbody fusion device

Intelivation Technologies

Intelivation Technologies has received US Food and Drug Administration (FDA) 510(k) clearance of the Advantage-C PEEK cervical interbody fusion device, which is designed to be used in skeletally mature patients in levels C2-T1 in conjunction with fixation for ACDF (anterior cervical discectomy and fusion) procedures.

Advantage-C was developed to optimise fusion, while maintaining elasticity that is similar to bone and radiolucency of the cage body.

Intelivation Technologies president, Amit Sinha, said: “I am excited about the FDA approval of Advantage-C and the myriad of efficiencies this device will bring to both surgeons and hospital systems alike.”

Rob Anderson, the firm’s CEO, added: “Our growing line of interbody devices further drives home our commitment to innovating cost-effective spinal solutions that consistently provide superior clinical results.”


Please enter your comment!
Please enter your name here